Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized versus intravenous naloxone for opium poisoning
IRCT20110514006481N14Phase 3Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of naloxone in opioid intoxication (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Blood pressure, Respiratory rate and 4 more. Started Dec 2020; status: completed.
02
Drugs
naloxone
03
Conditions
opioid intoxication
Beyond the preview
Go deeper on IRCT20110514006481N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110514006481N14.